脑血管病防治：从心脑血管病联防联治谈起(16)
[129] Gaziano JM， Brotons C， Coppolecchia R， et al. Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE)： a randomised， double-blind， placebo-controlled trial[J]. Lancet， 2018， 392(10152)：1036-1046.[130] Bhatt DL. Aspirin-still the GLOBAL LEADER in antiplatelet therapy[J]. Lancet ......
您现在查看是摘要页，全文长 2792 字符。